- Home
- JBGS vs LENZ Comparison
JBGS vs LENZ Comparison
Compare JBGS & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBGS
- LENZ
- Stock Information
- Founded
- JBGS 2016
- LENZ 2019
- Country
- JBGS United States
- LENZ United States
- Employees
- JBGS N/A
- LENZ N/A
- Industry
- JBGS Real Estate Investment Trusts
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- JBGS Real Estate
- LENZ Health Care
- Exchange
- JBGS Nasdaq
- LENZ Nasdaq
- Market Cap
- JBGS 1.4B
- LENZ 1.2B
- IPO Year
- JBGS 2017
- LENZ 2021
- Fundamental
- Price
- JBGS $21.58
- LENZ $31.84
- Analyst Decision
- JBGS Sell
- LENZ Strong Buy
- Analyst Count
- JBGS 2
- LENZ 4
- Target Price
- JBGS $17.00
- LENZ $56.25
- AVG Volume (30 Days)
- JBGS 589.8K
- LENZ 1.2M
- Earning Date
- JBGS 10-28-2025
- LENZ 11-05-2025
- Dividend Yield
- JBGS 3.24%
- LENZ N/A
- EPS Growth
- JBGS N/A
- LENZ N/A
- EPS
- JBGS N/A
- LENZ N/A
- Revenue
- JBGS $513,301,000.00
- LENZ $5,000,000.00
- Revenue This Year
- JBGS N/A
- LENZ N/A
- Revenue Next Year
- JBGS $2.33
- LENZ $285.82
- P/E Ratio
- JBGS N/A
- LENZ N/A
- Revenue Growth
- JBGS N/A
- LENZ N/A
- 52 Week Low
- JBGS $13.28
- LENZ $16.54
- 52 Week High
- JBGS $24.30
- LENZ $50.40
- Technical
- Relative Strength Index (RSI)
- JBGS 53.54
- LENZ 33.24
- Support Level
- JBGS $20.19
- LENZ $30.66
- Resistance Level
- JBGS $21.09
- LENZ $42.98
- Average True Range (ATR)
- JBGS 0.55
- LENZ 3.10
- MACD
- JBGS 0.09
- LENZ -1.51
- Stochastic Oscillator
- JBGS 79.50
- LENZ 7.69
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.